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Abstract
The poxvirus 2L protein binds tumor necrosis factor-α (TNFα) to inhibit host antiviral and immune
responses. The 2.8-Å 2L–TNFα structure reveals three symmetrically arranged 2L molecules per
TNFα trimer. 2L resembles class I major histocompatibility complex (MHC) molecules but lacks a
peptide-binding groove and β2-microglobulin light chain. Overlap between the 2L and host TNF
receptor-binding sites on TNFα rationalizes 2L inhibition of TNFα–TNF receptor interactions and
prevention of TNFα-induced immune responses.
Poxviruses express a wide range of secreted proteins that interfere with the vertebrate immune
response1. The pro-inflammatory cytokine TNFα is a common target for inhibition by secreted
poxviral proteins, including virally encoded homologs of TNF receptors (TNFRs)2,3. A class
of secreted TNFα inhibitor that is not homologous to viral or host TNFRs was recently
identified from Tanapox virus (TPV)4 and related viruses (Supplementary Fig. 1). The TPV
2L protein binds human TNFα with very high affinity (Kd = 43 pM), thereby effectively
sequestering TNFα to prevent activation of TNF receptors and downstream antiviral effects
such as TNF-induced apoptosis4.
Although 2L proteins are distantly related to extracellular regions of MHC class I molecules
(∼13% sequence identity)4 (Supplementary Fig. 2), 2L from the Yaba-like disease virus (98%
identical to TPV 2L; Supplementary Fig. 1) did not co-purify with β2-microglobulin (β2m, the
class I MHC light chain) when expressed in insect cells (data not shown). We determined the
structure of the 2L–TNFα complex to 2.8-Å resolution by molecular replacement
(Supplementary Table 1 and Supplementary Methods; Rcryst = 23.6%, Rfree = 26.6%). The
structure revealed a central TNFα trimer bound by three symmetrically arranged 2L molecules,
analogous to a three-fold symmetric host TNFR–TNF complex (TNFR1 bound to TNFβ
(lymphotoxin α)5) (Fig. 1).
In common with classical class I MHC molecules and MHC homologs, a diverse family that
includes host and viral proteins with immune and non-immune functions6, the 2L structure
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also includes an α1-α2 superdomain (an antiparallel β-sheet that is topped by two α-helices)
and an α3 domain (an immunoglobulin constant region fold) (Supplementary Fig. 3a,b).
Disulfide bonds are found in the expected positions for class I MHC molecules and homologs:
one linking the α2 domain helix to the β-sheet floor of the α1-α2 platform and one joining the
two β-sheets in the α3 domain. An additional disulfide bond near the C terminus joins residues
separated by 3 residues (Supplementary Fig. 2).
Similar to many class I MHC homologs, 2L does not contain a noticeable groove between its
α1 and α2 helices (groove surface area of 60 Å2) (Supplementary Fig. 3c and Supplementary
Table 2), and there was no unexplained electron density in this region. In this regard, 2L is
more similar to HFE and FcRn (groove surface areas of 415 Å2 and 235 Å2, respectively)7,
which do not present endogenous peptides, than it is to classical peptide-binding class I MHC
molecules, the peptide-binding viral homolog UL18 or the lipid-presenting CD1d1 protein
(groove surface areas of ∼760 Å2, 900 Å2 and 1440 Å2, respectively)7–9. Thus 2L is not
expected to bind/present endogenous peptides or other antigens.
Groove closure in 2L is accomplished by displacement of the N-terminal half of each helix
toward the opposite helix and insertion of large side chains, including Trp69 and Met140, which
would prevent binding of a peptide antigen (Supplementary Fig. 3b). The 2L α1 helix is shorter
than its MHC counterpart (Supplementary Fig. 2) because it includes irregular structure
extending toward the α2 domain. The beginning of the 2L α1 domain helix is anchored by the
insertion of Tyr64 into a hydrophobic pocket within the α1 domain. The irregular structure
preceding the long helix positions His58 of the α1 domain almost over the α2 helix, where it
interacts with Tyr87 of TNFα.
The 2L α3 domain includes an unusual large insertion between α3 strands C and D (residues
220–252) (Fig. 1 and Supplementary Figs. 2 and 3a,d). This insertion makes extensive contacts
with the α1-α2 platform underside, resulting in an α3 domain and platform quaternary
arrangement that differs markedly from β2m-binding MHC molecules and homologs. Whereas
the distal end of the α3 domain in β2m-binding MHC molecules is positioned almost directly
under the α1-α2 platform center, the 2L α3 domain is tilted ∼42° toward the α2 portion of the
platform and also rotated ∼40° about its long axis as compared with its counterpart in HLA-
A2 (Supplementary Fig. 3e).
The solvent-accessible surface area buried at the 2L platform–α3 interface (1,970 Å2) is
comparable to the area buried at the HLA-A2 platform interface with both its α3 and β2m
domains (2,080 Å2), but most of the HLA-A2 interface area results from platform interactions
with β2m (1,520 Å2). The large interdomain area in 2L suggests that the α3 domain C-D loop,
particularly residues 242–246, has a role analogous to β2m in other MHC molecules; that is,
it establishes the relative orientation of α3 with respect to the α1-α2 platform (Supplementary
Fig. 3d). In 2L, extensive contacts between the platform and the α3 insertion, interactions
between α3 and the α2 domain β5-β6 loop and ionic interactions between the N-terminal amino
group and acidic residues (Asp211 and Asp286) in proximal loops of the α3 domain presumably
lock the position of α3 with respect to the α1-α2 platform. This effectively pre-organizes the
TNFα-binding surface, which involves residues from all three 2L domains (Supplementary
Fig. 3e).
Although the position of the 2L α3 domain does not overlap with β2m's location in MHC class
I–like molecules, N-linked glycosylation at Asn6 under the 2L α1-α2 platform (Supplementary
Fig. 3a) would prevent the canonical β2m interaction. The corresponding residue in the non–
β2m-binding protein MIC-A (suggested to be the source of 2L proteins by horizontal gene
transfer10) is also glycosylated11. In addition, the altered position of the 2L α3 domain is not
compatible with simultaneous binding of β2m to the α1-α2 platform and to α3 (Supplementary
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Fig. 3f). Thus, it seems that 2L lacks β2m to allow the α3 domain to be brought closer to the
α2 helix to form a larger TNFα-binding site (Fig. 2).
2L binds to TNFα using a large and highly complementary interface (Fig. 2a,b), rationalizing
the picomolar affinity between 2L and TNFα4. The binding site spans nearly 40 Å, and the
total buried surface area at the 2L–TNFα interface (2,060 Å2, of which 2L contributes 1,030
Å2 and adjacent TNFα subunits contribute 710 Å2 and 320 Å2) is larger than typical protein-
protein interfaces (1,560–1,700 Å2)12. The interface is also highly complementary, as assessed
by the shape complementarity index (SC)13 (SC = 0.72 for 2L–TNFα,where a value of 0.0
indicates no complementarity and 1.0 indicates a perfect fit), compared with antibody-antigen
interfaces (SC = 0.64–0.68)13. The TNFR1–TNFβ interface is less complementary (SC = 0.64),
but buries a similar surface area (2,120 Å2, with 1,090 Å2 from TNFR1 and 530 Å2 and 510
Å2 from adjacent TNFβ subunits).
2L inhibition of TNFα–TNFR interactions is rationalized by overlap between the 2L- and
TNFR-binding sites on the TNF trimer (Fig. 1). Residues from all three 2L domains contribute
to binding to TNFα at the shallow groove between adjacent TNFα subunits, burying loops D-
E and A-A′ (also crucial for TNFα binding to TNFR1 and TNFR2 (ref. 14) and TNFβ binding
to TNFR1 (ref. 5)) (Figs. 1 and 2 and Supplementary Table 3). Given the high (picomolar)
affinity of the 2L–TNFα interaction, we assume that 3:3 2L–TNFα complexes are formed in
vivo. However, formation of 3:3 2L–TNFα complexes may not be necessary for inhibition of
signaling through TNFR because this kind of signaling requires multiple intact TNFR-binding
sites on TNF, as demonstrated by inhibition of signaling when TNF exchanges subunits with
dominant-negative TNF variants15.
The structure of TNFα shows few changes upon binding to 2L (Supplementary Fig. 4). The
2L–TNFα interface primarily involves TNFα D-E loop residues 86–87 and A-A′ loop residues
30–34 from the neighboring subunit interacting with 2L α2 helix residues 157–175; for
example, the side chain of TNFα Tyr87 in the D-E loop, a crucial residue for binding both
TNFRs14, contacts the kink in the 2L α2 domain helix and makes a hydrogen bond with His58
from the α1 helix (Fig. 2c). Some features of the TNF-binding sites for 2L and host TNFRs
differ: G-H loop residues (Asp143 and Glu146) and residues in the E-F loop (part of the
TNFα-binding site for TNFR1 (ref. 16)) do not contact 2L, and TNFα strand B′, which interacts
with the insertion in the 2L α3 domain, is not part of the site for host TNFR binding.
Unlike host TNFRs, 2L does not bind to TNFβ or other TNF family members4. Superimposing
TNFβ onto the 2L–TNFα structure shows no main chain steric clashes (data not shown),
suggesting the specificity of 2L for TNFα is related to complementarity between acidic (2L
Glu99 and Asp289) and basic (TNFα A′-A″ loop Arg31 and Arg32) residues, which are not
present in TNFβ (Supplementary Fig. 5). Binding of TNFβ may be also prevented by different
positions of the TNF D-E loops (residues 85–89 in TNFα and residues 106–110 in TNFβ),
which differ by ∼2.5 Å (measured between the Cα atoms of analogous residues: TNFα Tyr87–
TNFβ Tyr108).
Anti-TNFα antibodies and TNF receptors are used clinically to inhibit autoimmune
inflammatory processes17. The 2L–TNFα structure reveals the molecular mechanism used by
poxviruses to attenuate host immune responses and thus provides further insight into how
TNFα may be modulated. The structure could facilitate efforts to develop 2L-based anti-
TNFα pharmaceuticals; specifically, efforts to minimize the immunogenicity of this viral
protein by removing T and B cell epitopes18 could be guided by identification of 2L residues
involved in TNFα binding and maintaining its tertiary structure.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Structure of 2L–TNFα and comparison with TNFR1–TNFβ. Disulfide bonds and ordered
carbohydrates on 2L are shown as yellow sticks. Left, the 2L–TNFα complex shown as a ribbon
diagram in two orientations: looking down the three-fold symmetry axis (above) and with the
three-fold axis vertical (middle). Below left, a surface representation of TNFα from the
complex structure, with the 2L-binding site highlighted in red at one of three interfaces on the
TNFα trimer (TNFα subunits are different shades of blue). Right, The TNFR1–TNFβ
structure5 shown as a ribbon diagram in analogous orientations (top and middle). Below right,
a surface representation of TNFβ from the complex structure with one of the TNFR1-binding
sites highlighted in red.
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Figure 2.
The 2L–TNFα interface. (a) Surface representations of 2L (left) and the 2L–TNFα complex
(right). 2L is magenta and TNFα subunits are different shades of blue-green. Contact surfaces
(≤4.0 Å) are highlighted in blue on 2L and red on TNFα. (b) Ribbon diagrams corresponding
to the surfaces shown above. The C terminus of 2L is distant from the TNFα-binding site,
rationalizing why truncations in this region did not affect binding to TNFα19. (c) Stereo close-
up view of 2L–TNFα interface, with the α3 domain insertion highlighted in blue.
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